KBLB (Kraig Biocraft Laboratories) Cash-to-Debt : 0.40 (As of Dec. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Kraig Biocraft Laboratories Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Kraig Biocraft Laboratories's cash to debt ratio for the quarter that ended in Dec. 2024 was 0.40.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Kraig Biocraft Laboratories couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2024.

The historical rank and industry rank for Kraig Biocraft Laboratories's Cash-to-Debt or its related term are showing as below:

KBLB' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.04 Med: 0.68 Max: No Debt
Current: 0.4

During the past 13 years, Kraig Biocraft Laboratories's highest Cash to Debt Ratio was No Debt. The lowest was 0.04. And the median was 0.68.

KBLB's Cash-to-Debt is ranked worse than
61.72% of 1549 companies
in the Chemicals industry
Industry Median: 0.7 vs KBLB: 0.40

Kraig Biocraft Laboratories Cash-to-Debt Historical Data

The historical data trend for Kraig Biocraft Laboratories's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Kraig Biocraft Laboratories Cash-to-Debt Chart

Kraig Biocraft Laboratories Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash-to-Debt

Get a 7-Day Free Trial

0.34

0.97

2.18

1.46

0.40

Kraig Biocraft Laboratories Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Cash-to-Debt	Get a 7-Day Free Trial															1.46	1.17	0.88	0.69	0.40

Competitive Comparison of Kraig Biocraft Laboratories's Cash-to-Debt

For the Specialty Chemicals subindustry, Kraig Biocraft Laboratories's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kraig Biocraft Laboratories's Cash-to-Debt Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Kraig Biocraft Laboratories's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Kraig Biocraft Laboratories's Cash-to-Debt falls into.

Save Embed

;

Save Embed

;

Kraig Biocraft Laboratories Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Kraig Biocraft Laboratories's Cash to Debt Ratio for the fiscal year that ended in Dec. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.673	/	(1.664	+	0.041)
	=	0.39

Kraig Biocraft Laboratories's Cash to Debt Ratio for the quarter that ended in Dec. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.673	/	(1.664	+	0.041)
	=	0.39

Kraig Biocraft Laboratories (OTCPK:KBLB) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Kraig Biocraft Laboratories Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Kraig Biocraft Laboratories's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Kraig Biocraft Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Kraig Biocraft Laboratories Inc (OTCPK:KBLB) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

2723 South State Street, Suite 150, Ann Arbor, MI, USA, 48104

Website

https://www.kraiglabs.com

Kraig Biocraft Laboratories Inc is engaged in the development of high-strength fibers using recombinant DNA technology mainly for commercial applications. It uses genetic engineering technologies to develop fibers with greater strength, resiliency, and flexibility for use in its target markets, namely the textile, specialty fiber, and technical textile industries. Its products include Monster Silk, which incorporates the natural elasticity of spider silk to make a silk fiber that is more flexible than conventional silk fibers and textiles; and Dragon Silk, which combines the elasticity of Monster Silk with additional high strength elements of native spider silk; Spydasilk; and Spydra.

Executives

Jonathan Richard Rice	officer: COO	2723 S STATE STREET, SUITE 150, ANN ARBOR MI 48104
Kimberly Kraig Thompson	director, 10 percent owner, officer: CEO, CFO	2723 S STATE STREET, SUITE 150, ANN ARBOR MI 48401